If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
97.00    0.00 (0.00%)
Bid:
94.00
Ask:
100.00
Spread: 6.00 (6.383%)
Market Cap: £105.90m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Director/PDMR Share Dealing

24 Dec 2021 08:14

RNS Number : 7553W
Inspecs Group PLC
24 December 2021
 

24 December 2021

Inspecs Group Plc

("Inspecs" the "Company" or "Group")

 

Director/PDMR Share Dealing

 

On 23 December 2021, the following options to acquire Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") were granted under the Inspecs Long Term Incentive Plan 2020 ("LTIP") to Robin Totterman and Chris Kay, the Chief Executive Officer and Chief Financial Officer respectively, of the Group. Each option entitled the optionholder to acquire 50,000 Ordinary Shares at an exercise price of 370 pence per Ordinary Share. The options vest on the 23 December 2024, being the third anniversary of grant, subject to the optionholder's continued employment with the Group.

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

a) Name

Christopher Kay

2. Reason for the notification

 

a) Position/status

Chief Financial Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Inspecs Group plc

b) LEI

2138008Z4S4DHR6NE933

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b) Identification code

GB00BK6JPP03

c) Nature of the transaction

Grant of options over 50,000 ordinary shares with an exercise price of 370 pence per share under the Inspecs Long Term Incentive Plan

d) Price(s) and volume(s)

 

Price(s)

Volume(s)

 

370 pence

50,000

e) Aggregated information:

i. Aggregated volume

ii. price

N/A

f) Date of the transaction

23 December 2021

g) Place of the transaction

Outside a trading venue

 

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

a) Name

Robin Totterman

2. Reason for the notification

 

a) Position/status

Chief Executive Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Inspecs Group plc

b) LEI

2138008Z4S4DHR6NE933

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b) Identification code

GB00BK6JPP03

c) Nature of the transaction

Grant of options over 50,000 ordinary shares with an exercise price of 370 pence per share under the Inspecs Long Term Incentive Plan

d) Price(s) and volume(s)

 

Price(s)

Volume(s)

 

370 pence

50,000

e) Aggregated information:

i. Aggregated volume

ii. price

N/A

f) Date of the transaction

23 December 2021

g) Place of the transaction

Outside a trading venue

 

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Will Bell

Tel: +44 (0) 20 7418 8900

 

FTI Consulting (Financial PR)

Alex Beagley

Alice Newlyn

Tel: +44 (0) 20 3727 1000

 

 

About Inspecs Group plc

 

Inspecs is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

 

In December 2020, Inspecs acquired Eschenbach, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. The acquisition extended the Group's presence internationally in key global markets. This followed the acquisition of lens maker Norville in July 2020, whereby Inspecs combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well positioned to continue to take market share in the globally expanding eyewear market.

 

Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.

 

Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

The Group's growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

More information is available at: www.INSPECS.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTFVLSFIL
Date   Source Headline
27th Oct 20227:00 amRNSTrading Update and Board Changes
20th Oct 202211:12 amRNSHolding(s) in Company
19th Oct 20224:18 pmRNSHolding(s) in Company
15th Sep 20225:44 pmRNSHolding(s) in Company
7th Sep 20227:00 amRNSDirector/PDMR Share Dealing
30th Aug 20224:52 pmRNSHolding(s) in Company
23rd Aug 20225:02 pmRNSHolding(s) in Company
18th Aug 20227:00 amRNSInterim Results
11th Aug 20223:31 pmRNSResult of AGM
11th Jul 20221:19 pmRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20222:26 pmRNSDirector/PDMR Dealing
29th Jun 202212:37 pmRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Final Results
7th Jun 20224:38 pmRNSHolding(s) in Company
31st May 202211:14 amRNSHolding(s) in Company
17th May 20225:41 pmRNSChange to Publication Date of Results
27th Apr 20227:00 amRNSQ1 Trading Update and Notice of Results
31st Mar 20224:17 pmRNSDirector/PDMR Share Dealing
18th Mar 202210:09 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSDirector/PDMR Share Dealing
1st Feb 20227:00 amRNSFull Year Trading Update
24th Jan 20227:00 amRNSHolding(s) in Company
11th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20227:00 amRNSAllotment of shares
24th Dec 20218:14 amRNSDirector/PDMR Share Dealing
23rd Dec 20217:00 amRNSAcquisition of Ego Eyewear
8th Dec 20217:00 amRNSAcquisition of BoDe
28th Oct 20217:00 amRNSQ3 Trading Update
20th Oct 20215:13 pmRNSHolding(s) in Company
8th Sep 20217:00 amRNSInterim Results
13th Aug 20217:00 amRNSNotice of Results
19th Jul 202111:42 amRNSResult of AGM
25th Jun 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20217:00 amRNSDirector/PDMR Dealing
18th Jun 20217:00 amRNSFinal Results
29th Apr 20217:00 amRNSQ1 Trading Update & Notice of Results
26th Feb 20217:00 amRNSDirector/PDMR LTIP Awards
8th Feb 20215:57 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFull Year Trading Update
13th Jan 20218:25 amRNSHolding(s) in Company
23rd Dec 20204:21 pmRNSDirector/PDMR LTIP Awards
11th Dec 20201:05 pmRNSHolding(s) in Company
11th Dec 202012:00 pmRNSHolding(s) in Company
11th Dec 202011:58 amRNSDirector/PDMR Share Dealings
10th Dec 20203:11 pmRNSEschenbach Acquisition satisfaction of condition
7th Dec 20201:01 pmRNSResult of General Meeting
20th Nov 20207:00 amRNSPublication of Circular and Notice of GM
19th Nov 20202:05 pmRNSResult of Placing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.